Article
Beyond Transposons: TIGD1 as a Pan-Cancer Biomarker and Immune Modulator
30 May 2025
Abstract excerpt
Background/Objectives: TIGD1 (Trigger Transposable Element Derived 1) is a recently identified oncogene with largely unexplored biological functions. Emerging evidence suggests its involvement in multiple cellular processes across cancer types. This study aimed to perform a comprehensive pan-cancer analysis of TIGD1 to evaluate its expression patterns, diagnostic utility, prognostic value, and association with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
